BioTechniquesVol. 38, No. 3 BenchmarksOpen AccessMethod for assigning double-stranded RNA structuresTrevor S. Brown & Philip C. BevilacquaTrevor S. BrownPennsylvania State University, University Park, PA, USA & Philip C. Bevilacqua*Address correspondence to: Philip C. Bevilacqua, Department of Chemistry, The Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA. e-mail: E-mail Address: pcb@chem.psu.eduPennsylvania State University, University Park, PA, USAPublished Online:30 May 2018https://doi.org/10.2144/05383BM04AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInReddit Secondary structural motifs of RNA are composed of single- and double-stranded regions. Double-stranded RNA (dsRNA) participates in the antiviral functions of the interferon-induced protein kinase PKR, gene regulation, and gene silencing, or RNA interference (RNAi) (1–4). Thus, it is important to have accurate methods for identifying double-stranded segments of RNA. Structure mapping with ribonuclease V1 (RNase V1), a double-stranded RNA-specific ribonuclease that also cleaves stacked single-stranded regions, is a common approach for detecting double-stranded segments (5–9). However, it has been uncertain how to assign bands.Standard enzymatic structure mapping involves limited digestion of an end-labeled RNA with various nucleases that are structure- or sequence-specific. Most commonly, the 5′ end of the RNA is radiolabeled, and digestion reactions are fractionated by denaturing polyacrylamide gel electrophoresis (PAGE) alongside hydrolysis and sequencing ladders. The hydrolysis ladder enables numbering of bands, while a sequencing ladder, such as an RNase T1 digestion (G-specific), enables assignment of bands (Figure 1). If the RNA is 5′ end labeled, then both ladders comprise labeled products with a 3′-terminal phosphate, as with many of the commonly used ribonucleases (e.g., RNases T2, A, U2, Phy M, and CL3). Conversely, RNase V1 leaves a 3′- terminal hydroxyl (5–9).Figure 1. Sequencing of RNase V1 structure mapping products.Lanes labeled OH- are an alkaline hydrolysis under denaturing conditions. Remaining lanes show limited digestions of 5′ end-labeled 39-mer under native conditions using RNases T1 (G-specific), V1 (dsRNA-specific), and A (C, U-specific). Lanes T-1 and T-2 are standard denaturing and native RNase T1 digestions, respectively. Lane T-3 is an ethanol-precipitated fraction of T-2 that was subsequently treated with T4 polynucleotide kinase (PNK) to remove the 3′-terminal phosphate. Lanes V-1 and V-2 are native digestions using 0.002 and 0.0001 U/µL RNase V1, respectively, showing a range of bands with a 3′-terminal hydroxyl. Lanes A-1 and A-2 are native digestions, whereas A-1 is an ethanol-precipitated fraction of A-2 that was subsequently treated with T4 PNK to remove the 3′-terminal phosphate. Sequence assignments of bands are shown along the sides of the gel. The left side provides assignments for the RNase T1 lanes (PNK-treated band assignments are indicated by a blue dot "•"), while the right side provides assignments for the RNase A lanes (PNK-treated band assignments are indicated by a red dot "•"). A "P" following a nucleotide indicates that it has a 3′-terminal phosphate, while an "OH" indicates absence of a 3′-terminal phosphate. The upper portion of the gel is reproduced at the top of the figure using a higher maximal intensity scale to allow details of this region to be discerned.Assigning structured regions digested by RNase V1 has been problematic. In some instances, the lengths of labeled RNase V1 products have been estimated by comparison to fragments produced by nonsequence-specific nucleases that leave the same termini, such as nuclease S1 or Mung Bean nuclease, combined with comparison to sequence-specific ribonucleases that leave the incorrect termini, such as RNase T1 (7)(10–12). However, this provides minimal confidence in assignments, since the relative electrophoretic gel mobility of various oligonucleotides with a 3′-terminal phosphate versus hydroxyl is unknown. While it has been demonstrated that short (<10 nt) RNase V1 products have reduced mobility relative to RNase T1 products (13,14), it is not obvious that the migration of these products should differ by only one nucleotide, as is commonly assumed. Moreover, since removal of the 3′-terminal phosphate has a large effect on charge but a minimal effect on size and shape, we reasoned that it might affect the mobility of even longer oligonucleotides (e.g., approximately =40 nt). Herein, we describe a simple method that produces appropriate RNase V1 sequencing ladders from T4 polynucleotide kinase (PNK) modification of RNase T1 and RNase A digests.In addition to phosphorylating the 5′ hydroxyl terminus of DNA or RNA, T4 PNK (New England Biolabs, Beverly, MA, USA) has a nonsequence-specific 3′ phosphatase activity that can remove a 2′-, 3′-, or 2′,3′-cyclic phosphate (15–17). We found T4 PNK useful for converting RNase T1 and RNase A sequencing ladders into ladders with 3′-terminal hydroxyls. A synthetic 39-nt RNA (Dharmacon, Lafayette, CO, USA), 5′-GGCCGGCAUGCUCCCAGCCUCCUCGCGGCGCCGGCUGGG-3′, was chosen for study since it contains double- and single-stranded segments and is long enough to allow terminal phosphate effects on electrophoretic mobility of short (20 nt) products to be determined. This oligonucleotide (39-mer) mimics a folding intermediate of the hepatitis delta virus (HDV) ribozyme (18). The 39-mer was 5′ end-labeled and subjected to limited digestions under native conditions by RNases T1, V1, and A and denaturing conditions by RNase T1 and alkaline hydrolysis (Figure 1). In certain instances, the RNase T1 and A digestions were followed by T4 PNK treatment.The 39-mer was deblocked according to the manufacturer's instructions and desalted on a C18 Sep-Pak® Cartridge (Waters, Milford, MA, USA). The resulting RNA pellet was suspended in 1× TE (10 mM Tris, pH 8.0, 1 mM EDTA) and 5′ end-labeled by T4 PNK using [γ-32P]ATP (PerkinElmer Life and Analytical Sciences, Boston, MA, USA). The labeled 39-mer was PAGE-purified [10% polyacrylamide (29:1)/7.0 M urea/1× Tris-borate EDTA (TBE)] and structure-mapped with RNases T1 (0.01 U/µL), V1 (0.002 and 0.0001 U/µL), and A (1 ng/mL). The RNA was heated to 90°C for 2 min and cooled on bench top for 10 min, followed by addition of RNA Structure buffer (Ambion, Austin, TX, USA). Titrations of nucleases (Ambion) were carried out to find the optimal single-digestion conditions. Digestion reactions were stopped using Inactivation/Precipitation buffer (Ambion), precipitated, and dissolved in sterile water. To afford complete removal of the 3′-terminal phosphate, digestion products (2.4 nM) were incubated with T4 PNK (1 U/µL; T4 PNK buffer) at 37°C for 30 min. T4 PNK treatment was also performed in situ with RNase T1, which allowed for partial elimination of the 3′ phosphate-terminated species (data not shown). Other conditions for driving complete removal of the terminal phosphate have been described (14,15,17). All samples were fractionated on a 20% polyacrylamide (29:1)/7 M urea/1× TBE gel (Figure 1).Comparing T4 PNK-treated (Figure 1, lanes T-3 and A-1) to T4 PNK-untreated (Figure 1, lanes T-2 and A-2) digestions revealed that the migrations of products are retarded in treated lanes. Next, we compared the RNase V1 digestions (Figure 1, lanes V-1 and V-2) to the T4 PNK-treated digestions. In all cases where a comparison was possible, RNase V1 products co-migrated with bands in treated lanes. Moreover, it is worth noting that, in many instances, bands in the hydrolysis ladder do not align with bands in the RNase V1 or T4 PNK-treated lanes. This effect is particularly noticeable for G1, C3, C4, G6, C7, A8, and G10 (Figure 1).The aforementioned assumption that short RNase V1 products migrate one nucleotide slower than RNase T1 and hydrolysis products would have led to incorrect labeling of several bands (e.g., G10 as C11 and G6 as C7 in Figure 1, lane T-3). Also, slower electrophoretic mobility of the T4 PNK-treated samples is found not only for shorter digestion products, but also for products longer than 30 nt (Figure 1).In summary, T4 PNK-modified RNase T1 and RNase A ladders enable definitive assignment of the products of an RNase V1 digestion. Modification of RNases T1 and A digestion products is a simple and efficient method that should be extendable to other ribonucleases such as RNase U2 (A-specific). This approach should lead to increased accuracy in the identification of biologically significant dsRNA structures. Indeed, very recently a PNK-treated RNase T1 ladder was used to align Dicer and RNase III-digested RNAs (19).AcknowledgementsWe thank Durga M. Chadalavada and the entire Bevilacqua Lab for continued support and encouragement. This work was supported by the National Institutes of Health (NIH) grant no. GM58709 to P.C.B. and a National Research Service Award (NRSA) Individual Fellowship (NIH) and an Alfred P. Sloan Scholarship to T.S.B.Competing Interests StatementThe authors declare no competing interests.References1. Fierro-Monti, I. and M.B. Mathews. 2000. Proteins binding to duplexed RNA: one motif, multiple functions. Trends Biochem. Sci. 25:241–246.Crossref, Medline, CAS, Google Scholar2. Hutvagner, G. and P.D. Zamore. 2002. RNAi: nature abhors a double-strand. Curr. Opin. Genet. Dev. 12:225–232.Crossref, Medline, CAS, Google Scholar3. Samuel, C.E., K.L. Kuhen, C.X. George, L.G. Ortega, R. Rende-Fournier, and H. Tanaka. 1997. The PKR protein kinase—an interferon-inducible regulator of cell growth and differentiation. Int. J. Hematol. 65:227–237.Crossref, Medline, CAS, Google Scholar4. Yakhnin, A.V. and P. Babitzke. 2002. NusA-stimulated RNA polymerase pausing and termination participates in the Bacillus subtilis trp operon attenuation mechanism in vitro. Proc. Natl. Acad. Sci. USA 99:11067–11072.Crossref, Medline, CAS, Google Scholar5. Boldyreva, L.G., A.S. Boutorine, and S.K. Vassilenko. 1978. Molecular weight distribution of products of hydrolysis of polyuridylic acid by cobra venom ribonuclease. Preparative production of polynucleotides with set molecular weight. Biokhimiya 43:1659–1664.Medline, CAS, Google Scholar6. Ehresmann, C., F. Baudin, M. Mougel, P. Romby, J.P. Ebel, and B. Ehresmann. 1987. Probing the structure of RNAs in solution. Nucleic Acids Res. 15:9109–9128.Crossref, Medline, CAS, Google Scholar7. Krol, A. and P. Carbon. 1989. A guide for probing native small nuclear RNA and ribonucleoprotein structures. Methods Enzymol. 180:212–227.Crossref, Medline, CAS, Google Scholar8. Lowman, H.B. and D.E. Draper. 1986. On the recognition of helical RNA by cobra venom V1 nuclease. J. Biol. Chem. 261:5396–5403.Crossref, Medline, CAS, Google Scholar9. Vassilenk, S.K. and V.C. Rythe. 1975. The isolation of highly purified ribonuclease from central Asian cobra (Naja oxiana) venom. Biokhimiya 40:578–582.Medline, Google Scholar10. Knapp, G. 1989. Enzymatic approaches to probing of RNA secondary and tertiary structure. Methods Enzymol. 180:192–212.Crossref, Medline, CAS, Google Scholar11. Lockard, R.E. and A. Kumar. 1981. Mapping tRNA structure in solution using double-strand-specific ribonuclease V1 from cobra venom. Nucleic Acids Res. 9:5125–5140.Crossref, Medline, CAS, Google Scholar12. Puglisi, J.D. and J.R. Wyatt. 1995. Biochemical and NMR studies of RNA conformation with an emphasis on RNA pseudoknots. Methods Enzymol. 261:323–350.Crossref, Medline, CAS, Google Scholar13. Favorova, O.O., F. Fasiolo, G. Keith, S.K. Vassilenko, and J.P. Ebel. 1981. Partial digestion of tRNA—aminoacyl-tRNA synthetase complexes with cobra venom ribonuclease. Biochemistry 20:1006–1011.Crossref, Medline, CAS, Google Scholar14. Povirk, L.F. and R.J. Steighner. 1990. High ionic strength promotes selective 3′-phosphatase activity of T4 polynucleotide kinase. BioTechniques 9:562.Medline, CAS, Google Scholar15. Cameron, V. and O.C. Uhlenbeck. 1977. 3′-Phosphatase activity in T4 polynucleotide kinase. Biochemistry 16:5120–5126.Crossref, Medline, CAS, Google Scholar16. Richardson, C.C. 1981. Bacteriophage T4 polynucleotide kinase, p. 299–314. In P.D. Boyer (Ed.), The Enzymes. Academic Press, New York.Crossref, Google Scholar17. Schurer, H., K. Lang, J. Schuster, and M. Morl. 2002. A universal method to produce in vitro transcripts with homogeneous 3′ ends. Nucleic Acids Res. 30:e56.Crossref, Medline, Google Scholar18. Brown, T.S., D.M. Chadalavada, and P.C. Bevilacqua. 2004. Design of a highly reactive HDV ribozyme sequence uncovers facilitation of RNA folding by alternative pairings and physiological ionic strength. J. Mol. Biol. 341:695–712.Crossref, Medline, CAS, Google Scholar19. Zhang, H., F.A. Kolb, L. Jaskiewicz, E. Westhof, and W. Filipowicz. 2004. Single processing center models for human Dicer and bacterial RNase III. Cell 118:57–68.Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByToxin MqsR cleaves single‐stranded mRNA with various 5' ends5 February 2016 | MicrobiologyOpen, Vol. 5, No. 3RNA structure replaces the need for U2AF2 in splicing13 November 2015 | Genome Research, Vol. 26, No. 1Recognition of duplex RNA by the deaminase domain of the RNA editing enzyme ADAR26 January 2015 | Nucleic Acids Research, Vol. 43, No. 2RNA Structural Analysis by Enzymatic Digestion27 September 2013Probing the sequence and structure of in vitro synthesized antisense and target RNAs from the replication control system of plasmid pMV158Plasmid, Vol. 70, No. 1The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element24 May 2013 | RNA, Vol. 19, No. 7Activation of PKR by RNA misfolding: HDV ribozyme dimers activate PKR25 October 2012 | RNA, Vol. 18, No. 12Mapping interactions between the RNA chaperone FinO and its RNA targets27 January 2011 | Nucleic Acids Research, Vol. 39, No. 10Substrate recognition by ribonucleoprotein ribonuclease MRP20 December 2010 | RNA, Vol. 17, No. 2Regulation of PKR by HCV IRES RNA: Importance of Domain II and NS5AJournal of Molecular Biology, Vol. 400, No. 3The Human HDV-like CPEB3 Ribozyme Is Intrinsically Fast-Reacting4 June 2010 | Biochemistry, Vol. 49, No. 25Selection and characterization of anti-NF-κB p65 RNA aptamers21 April 2008 | RNA, Vol. 14, No. 6Duality of polynucleotide substrates for Phi29 DNA polymerase: 3′→5′ RNase activity of the enzyme29 January 2008 | RNA, Vol. 14, No. 3Structural and functional analyses of stem–loop 1 of the Sindbis virus genomeVirology, Vol. 370, No. 1Characterization of the structure, function, and mechanism of B2 RNA, an ncRNA repressor of RNA polymerase II transcription16 February 2007 | RNA, Vol. 13, No. 4Catalysis and Rational Engineering of trans-Acting pH6DZ1, an RNA-Cleaving and Fluorescence-Signaling Deoxyribozyme with a Four-Way Junction Structure3 August 2006 | ChemBioChem, Vol. 7, No. 9Phosphoester-transfer mechanism of an RNA-cleaving acidic deoxyribozyme revealed by radioactivity tracking and enzymatic digestionChemical Communications, Vol. 125, No. 22 Vol. 38, No. 3 Follow us on social media for the latest updates Metrics History Received 11 August 2004 Accepted 20 October 2004 Published online 30 May 2018 Published in print March 2005 Information© 2005 Author(s)AcknowledgementsWe thank Durga M. Chadalavada and the entire Bevilacqua Lab for continued support and encouragement. This work was supported by the National Institutes of Health (NIH) grant no. GM58709 to P.C.B. and a National Research Service Award (NRSA) Individual Fellowship (NIH) and an Alfred P. Sloan Scholarship to T.S.B.Competing Interests StatementThe authors declare no competing interests.PDF download
No takes yet. Share an insight, caveat, or question.
Brown et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: